Related Experiment Video
Updated: May 12, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and
Xiang Liu1, Liying Du, Renqing Feng
1Department of Biochemistry and Molecular Biology, College of Life Sciences, Peking University, Beijing 100871, China.
Abstract:
We have demonstrated that c-Src suppression inhibited the epithelial to mesenchymal transition in human breast cancer cells. Here, we investigated the role of c-Src on the cell cycle progression using siRNAs and small molecule inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). Western blot analysis demonstrated the down-regulation of cyclin D1 and cyclin E and up-regulation of p27 Kip1 after c-Src suppression by PP2. Incubation of cells in the presence of PP2 significantly blocked the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2), protein kinase B (AKT), and glycogen synthase kinase 3 beta (GSK3β). Specific pharmacological inhibitors of MEK1/2/ERK1/2 and phosphatidylinositide 3-kinase/AKT pathways were used to demonstrate the relationship between the signal cascade and cell cycle proteins expression. The expression of cyclin D1 and cyclin E were decreased after inhibition of ERK1/2 or AKT activity, whereas the p27 Kip1 expression was increased. In addition, knockdown of c-Src by siRNAs reduced cell proliferation and phosphorylation of ERK1/2, AKT, and GSK3β. After c-Src depletion by siRNAs, we observed significant down-regulation of cyclin D1 and cyclin E, and up-regulation of p27 Kip1. These results suggest that c-Src suppression by PP2 or siRNAs may regulate the progression of cell cycle through AKT/GSK3β and ERK1/2 pathways.
Insights
c-Src suppression inhibits cell cycle progression in breast cancer by down-regulating cyclin D1/E and up-regulating p27 Kip1. This occurs via the AKT/GSK3β and ERK1/2 signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- c-Src is implicated in epithelial to mesenchymal transition in breast cancer.
- Understanding c-Src's role in cell cycle regulation is crucial for cancer therapy.
Purpose of the Study:
- To investigate the role of c-Src in cell cycle progression.
- To elucidate the signaling pathways involved in c-Src-mediated cell cycle regulation.
Main Methods:
- Utilized small molecule inhibitor PP2 and siRNAs to suppress c-Src.
- Performed Western blot analysis for cell cycle proteins (cyclin D1, cyclin E, p27 Kip1).
- Assessed phosphorylation of key signaling molecules (ERK1/2, AKT, GSK3β) and used pathway-specific inhibitors.
Main Results:
- c-Src suppression led to decreased cyclin D1/E and increased p27 Kip1 expression.
- PP2 treatment inhibited phosphorylation of ERK1/2, AKT, and GSK3β.
- Inhibition of AKT/GSK3β or ERK1/2 pathways mimicked the effects of c-Src suppression on cell cycle proteins.
Conclusions:
- c-Src plays a significant role in regulating breast cancer cell cycle progression.
- The AKT/GSK3β and ERK1/2 signaling pathways are critical mediators of c-Src's effects on cell cycle proteins.
- Targeting c-Src may represent a viable therapeutic strategy for breast cancer.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
MAPK Signaling Cascades
Mitogens and the Cell Cycle

